FDA Adverse Event Malfunction Summary report: N

REAGENT RED BLOOD CELLS BIOTESTCELL 1&2

MDR report key: 2580777 · Received May 21, 2012

Report

Report Number
9610824-2012-00076
Event Type
Malfunction
Date Received
May 21, 2012
Date of Event
April 24, 2012
Report Date
May 21, 2012
Manufacturer
BIO-RAD MEDICAL DIAGNOSTICS GMBH
Product Code
KSZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS IS OUR COMBINED INITIAL AND FINAL REPORT ON THIS INCIDENT

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT CELL #2 OF BIOTESTCELL 1&2, YIELDED FALSE POSITIVE ANTIBODY SCREENING TEST RESULTS IN THE TUBE TECHNIQUE AND THE ORTHO GEL METHODOLOGY. THE SUPPOSEDLY DEFECTIVE PRODUCT WAS RETURNED, BUT NONE OF THE PATIENT SAMPLES THAT HAD CAUSED FALSE POSITIVE TEST RESULTS. OUR QUALITY CONTROL LABORATORY TESTED THE SUPPOSEDLY DEFECTIVE PRODUCT WITH DIFFERENT DONOR SAMPLES, AND POSITIVE AND NEGATIVE CONTROLS IN SOLIDSCREEN II ON TANGO AND IN THE TUBE TECHNIQUE. ALL POSITIVE AND NEGATIVE REACTIONS WERE CORRECT. WE DID NOT OBSERVE ANY FALSE POSITIVE REACTIONS. THE GEL CARD SYSTEM IS NOT SUITABLE FOR THE CUSTOMER´S INTENDED APPLICATION: DETECTION OF UNEXPECTED ANTIBODIES. IN THIS CASE, WE RECOMMEND THE TUBE TEST AND SOLID PHASE TEST SOLIDSCREEN II WITH TANGO OPTIMO. TESTING BY OUR QUALITY CONTROL LABORATORY CONFIRMED THE ALLEGEDLY DEFECTIVE LOT OF BIOTESTCELL 1&2, FUNCTIONS CORRECTLY. A REVIEW OF THE BATCH RECORD DOCUMENTATION SHOWED NO IRREGULARITIES, WHICH MIGHT HAVE NEGATIVELY AFFECTED THE QUALITY OF THE ALLEGEDLY DEFECTIVE LOT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 REAGENT RED BLOOD CELLS BIOTESTCELL 1&2 BIOTESTCELL 1&2 KSZ BIO-RAD MEDICAL DIAGNOSTICS GMBH 8211011

Patients

Seq Age Sex Outcome Treatment
1 BIOTESTCELL-I11, LOT 8213011, EXP. 05/15/2012| BIOTESTCELL-I11 PLUS, LOT 8211011, EXP. 05/01/2012